In glioma, the most common fusion partner of FGFR3 is TACC3, and the fusion process of FGFR3–TACC3, which requires HSP90, requires the involvement of cell division cycle 37 (CDC37).270. The gene discussed is FGFR3; the disease is central nervous system cancer.